Loading ......
Filter By Product Search for
HSPA1A
HSPA1A Full Name
heat shock 70kD protein 1A
HSPA1A Introduction
HSPA1A (heat shock 70kD protein 1A), a major member of the heat shock protein 70 (HSP70) family, is a highly conserved molecular chaperone that plays a central role in maintaining cellular proteostasis under physiological and stress conditions. Many researchers and drug developers focus on HSPA1A because protein misfolding, cellular stress, and treatment resistance remain major challenges in cancer biology and other complex diseases. Under stress stimuli such as heat shock, oxidative stress, inflammation, or cytotoxic drugs, HSPA1A expression is rapidly upregulated to assist in protein folding, prevent protein aggregation, and facilitate the refolding or degradation of damaged proteins. Through these protective mechanisms, HSPA1A helps cells survive hostile environments, which is beneficial for normal tissue homeostasis but can become problematic when exploited by tumor cells. As a result, HSPA1A has gained significant attention as both a biomarker of cellular stress and a potential therapeutic target in oncology and stress-related diseases.

Functionally, HSPA1A regulates a broad range of cellular processes beyond its classical chaperone activity. It participates in protein quality control, apoptosis regulation, immune signaling, and cytoskeletal dynamics, allowing cells to rapidly adapt to environmental and metabolic stress. Recent studies have shown that HSPA1A can cooperate with signaling molecules that control cell migration and structural remodeling. For example, a 2025 study demonstrated that the small GTPase RhoA functionally collaborates with HSPA1A to promote the migratory phenotype of cancer cells. By influencing cytoskeletal reorganization, cell adhesion, and membrane protrusion formation, the HSPA1A–RhoA axis enhances cellular motility, a critical step in tumor invasion and metastasis. Additional research has also revealed that heat-induced changes in phosphatidylserine distribution can drive HSPA1A translocation to the plasma membrane. This membrane-localized form of HSPA1A (mHSPA1A) has been associated with aggressive tumor behavior and increased resistance to anticancer therapies, highlighting a new dimension of HSPA1A biology that extends beyond the cytosol.
Accumulating evidence further links HSPA1A to the development and progression of multiple human diseases, particularly cancers. In a 2026 study focusing on gastric cancer progression and chemosensitivity, cancer-associated fibroblasts (CAFs) were shown to secrete HSPA1A into the tumor microenvironment, significantly promoting tumor cell proliferation. Analysis of GEO datasets and immunohistochemical evaluation of more than one hundred gastric cancer tissue samples confirmed that elevated HSPA1A expression correlates with key clinicopathological characteristics, suggesting its potential value as a diagnostic and prognostic biomarker. Similarly, integrative analyses of ubiquitination-related gene networks in colorectal cancer have identified HSPA1A as a critical regulatory factor involved in tumor progression. Although the precise molecular mechanisms remain under investigation, these findings collectively suggest that HSPA1A contributes to tumor growth, metastasis, and therapeutic resistance across multiple cancer types. Consequently, targeting HSPA1A or modulating its cellular localization and signaling interactions may represent a promising strategy for developing next-generation anticancer therapies.
Alternate Names for HSPA1A
HSPA1A; heat shock 70kD protein 1A; HSP72; Hspa1; Hspa1b; Hsp70-1; heat shock 70 kDa protein 1A/1B; HSP70.1/2; HSP70-1/HSP70-2; HSP70.1/HSP70.2; heat shock protein 70-1; heat shock 70 kDa protein 1/2;
Loading ......